Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26FNL9G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,571
Award facts
- Contract value 100% obligated
- $6,571.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules on November 3, 2025, with a ceiling value of $6,571.00 and an ultimate completion date of November 4, 2025. This competitively awarded, firm fixed-price delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The contract involves no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical supplier of medical products to military and veteran healthcare systems through its comprehensive agreement with DLA. The company's federal contract portfolio demonstrates extensive capability in delivering a broad range of pharmaceutical products, including specialty medications, generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Creon DR—an enzyme replacement therapy used to treat pancreatic insufficiency—exemplifies the company's role in supporting the Defense Health Agency and other government healthcare systems through the flexible DLA pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26FNL9G?
SPE2DR26FNL9G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 3, 2025.
How much is contract SPE2DR26FNL9G worth?
The government has obligated $6,571 on SPE2DR26FNL9G.
Is contract SPE2DR26FNL9G an order under another contract?
Yes. SPE2DR26FNL9G is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNL9G competed?
The extent of competition for SPE2DR26FNL9G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award